Ulcerative Colitis Clinical Trials in Los Angeles

Showing 601-602 of 602 trials

CORE: A Study of OPC-6535 With Asacol® in Maintaining Ulcerative Colitis (UC) Remission

NCT00092508

This dose comparison study, taking place at over 200 sites worldwide, will compare the dosing, safety and efficacy of an investigational medicine OPC-6535 to the dosing, safety and efficacy of Asacol ® in the maintenance of remission in subjects with ulcerative colitis.

Ulcerative Colitis

Otsuka Pharmaceutical Development & Commercialization, Inc.1,725 participantsStarted May 2004

Huntsville, Alabama, United States • Los Angeles, California, United States • Hollywood, Florida, United States +23 more locations

CORE: A Study of OPC-6535 With Asacol® in Maintaining Ulcerative Colitis (UC) Remission

Ulcerative Colitis Trials in Other Cities

Additivity Study: Additive Effect on Eye Pressure of Azopt and Alphagan P to Travatan

Other Conditions in Los Angeles